Hap Trading, LLC Immuno Gen, Inc. Call Options Transaction History

Hap Trading, LLC

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $1.25 Million - $3 Million	100,000 New	100,000 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $45,955 - $63,730	10,100 New	10,100 $3,000
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $10,395 - $19,008	-3,300 Reduced 14.47%	19,500 $7,000
Q1 2022 May 12, 2022	BUY	$4.26 - $7.48 $3,834 - $6,732	900 Added 4.11%	22,800 $11,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $104,025 - $164,250	21,900 New	21,900 $19,000
Q3 2021 Nov 10, 2021	SELL	$5.02 - $6.59 $91,363 - $119,938	-18,200 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.79 - $8.6 $105,378 - $156,520	18,200 New	18,200 $1,000
Q1 2021 May 14, 2021	SELL	$6.5 - $10.53 $81,900 - $132,678	-12,600 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $6,290 - $13,022	-1,700 Reduced 11.89%	12,600 $11,000
Q3 2020 Nov 13, 2020	BUY	$3.45 - $4.89 $49,335 - $69,927	14,300 New	14,300 $2,000
Q1 2020 May 08, 2020	SELL	$2.12 - $6.8 $23,108 - $74,120	-10,900 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.25 - $5.8 $24,525 - $63,220	10,900 New	10,900 $10,000
Q3 2019 Nov 12, 2019	SELL	$2.22 - $3.39 $428,682 - $654,609	-193,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $27,540 - $50,490	-15,300 Reduced 7.34%	193,100 $1,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $284,380 - $697,380	118,000 Added 130.53%	208,400 $5,000
Q1 2018 May 11, 2018	BUY	$6.7 - $12.95 $605,680 - $1.17 Million	90,400 New	90,400 $17,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.